» Articles » PMID: 21994606

Targets for the Induction of Protective Immunity Against Influenza a Viruses

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2011 Oct 14
PMID 21994606
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The current pandemic caused by the new influenza A(H1N1) virus of swine origin and the current pandemic threat caused by the highly pathogenic avian influenza A viruses of the H5N1 subtype have renewed the interest in the development of vaccines that can induce broad protective immunity. Preferably, vaccines not only provide protection against the homologous strains, but also against heterologous strains, even of another subtype. Here we describe viral targets and the arms of the immune response involved in protection against influenza virus infections such as antibodies directed against the hemagglutinin, neuraminidase and the M2 protein and cellular immune responses directed against the internal viral proteins.

Citing Articles

Evolutionary pressures rendered by animal husbandry practices for avian influenza viruses to adapt to humans.

de Camargo M, Caetano A, Ferreira de Miranda Santos I iScience. 2022; 25(4):104005.

PMID: 35313691 PMC: 8933668. DOI: 10.1016/j.isci.2022.104005.


New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.

Rohde J, Amann R, Rziha H PLoS One. 2013; 8(12):e83802.

PMID: 24376753 PMC: 3869816. DOI: 10.1371/journal.pone.0083802.


In vitro assessment of the immunological significance of a human monoclonal antibody directed to the influenza a virus nucleoprotein.

Bodewes R, Geelhoed-Mieras M, Wrammert J, Ahmed R, Wilson P, Fouchier R Clin Vaccine Immunol. 2013; 20(8):1333-7.

PMID: 23761662 PMC: 3754521. DOI: 10.1128/CVI.00339-13.


Influenza Virus-like Particle Containing Two Different Subtypes of Hemagglutinin Confers Protection in Mice Against Lethal Challenge With A/PR8 (H1N1) and A/HK (H3N2) Viruses.

Rezaei F, Mirshafiey A, Shahmahmoodi S, Shoja Z, Ghavami N, Mokhtari-Azad T Iran Red Crescent Med J. 2013; 15(1):75-82.

PMID: 23487492 PMC: 3589784. DOI: 10.5812/ircmj.6252.


Recombinant influenza vaccines.

Sedova E, Shcherbinin D, Migunov A, Smirnov I, Logunov D, Shmarov M Acta Naturae. 2013; 4(4):17-27.

PMID: 23346377 PMC: 3548171.


References
1.
Prasad S, Norbury C, Chen W, Bennink J, Yewdell J . Cutting edge: recombinant adenoviruses induce CD8 T cell responses to an inserted protein whose expression is limited to nonimmune cells. J Immunol. 2001; 166(8):4809-12. DOI: 10.4049/jimmunol.166.8.4809. View

2.
Flynn K, Belz G, Altman J, Ahmed R, Woodland D, Doherty P . Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 1998; 8(6):683-91. DOI: 10.1016/s1074-7613(00)80573-7. View

3.
SONOGUCHI T, Naito H, Hara M, Takeuchi Y, FUKUMI H . Cross-subtype protection in humans during sequential, overlapping, and/or concurrent epidemics caused by H3N2 and H1N1 influenza viruses. J Infect Dis. 1985; 151(1):81-8. DOI: 10.1093/infdis/151.1.81. View

4.
Goy K, Von Bibra S, Lewis J, Laurie K, Barr I, Anderson D . Heterosubtypic T-cell responses against avian influenza H5 haemagglutinin are frequently detected in individuals vaccinated against or previously infected with human subtypes of influenza. Influenza Other Respir Viruses. 2009; 2(4):115-25. PMC: 4634225. DOI: 10.1111/j.1750-2659.2008.00046.x. View

5.
McHeyzer-Williams L, McHeyzer-Williams M . Antigen-specific memory B cell development. Annu Rev Immunol. 2005; 23:487-513. DOI: 10.1146/annurev.immunol.23.021704.115732. View